Cargando…
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
BACKGROUND: The aim of this work was to investigate the outcome of metastasis-directed radiotherapy (MDT) in prostate cancer patients with bone metastases following current ESTRO/EORTC subclassifications for oligometastatic disease. METHODS: Clinical data of 80 consecutive oligometastatic patients w...
Autores principales: | Rogowski, Paul, Trapp, Christian, von Bestenbostel, Rieke, Schmidt-Hegemann, Nina-Sophie, Shi, Run, Ilhan, Harun, Kretschmer, Alexander, Stief, Christian, Ganswindt, Ute, Belka, Claus, Li, Minglun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247211/ https://www.ncbi.nlm.nih.gov/pubmed/34193194 http://dx.doi.org/10.1186/s13014-021-01849-8 |
Ejemplares similares
-
Radiotherapy of oligometastatic prostate cancer: a systematic review
por: Rogowski, Paul, et al.
Publicado: (2021) -
Radiotherapy in oligometastatic prostate cancer—a pattern of care survey among members of the German Society for Radiation Oncology (DEGRO)
por: Rogowski, Paul, et al.
Publicado: (2022) -
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
por: Rogowski, Paul, et al.
Publicado: (2021) -
PSMA-positive nodal recurrence in prostate cancer: Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2020) -
Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2018)